CLARIFY
DEAD

Serial Number

90836111

Owner

Precision Therapeutics, LLC

Attorney

Courtney Thompson

Filing Date

Jul 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CLARIFY Trademark

Serial Number: 90836111

CLARIFY is a trademark filed by Precision Therapeutics, LLC on July 19, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Precision Therapeutics, LLC (2 trademarks)

24 Park Avenue, #181
Park Ridge, NJ 07656

Entity Type: 16

Trademark Details

Filing Date

July 19, 2021

Registration Date

Not Registered

Published for Opposition

October 4, 2022

Goods & Services

Real time Polymerase Chain Reaction lyophilized products for medical laboratories, namely, analyzers and apparatus for testing blood or bodily fluids for medical diagnostic purposes; Nasopharyngeal testing devices in the nature of probes for detection of infectious disease; Medical diagnostic testing apparatus for detection of nucleic acid from SARS-CoV-2; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Cell-based medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Rapid medical diagnostic testing apparatus for testing for Influenza A, Influenza B, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV- 2, Coronavirus, and respiratory illnesses for point of care, laboratory, and home use; Medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo; Rapid medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo; Medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo for point of care, laboratory, and home use; Medical diagnostic testing apparatus for medical oncology use; Rapid medical diagnostic testing apparatus for medical oncology use; Medical diagnostic testing apparatus for medical oncology use for oncology for point of care, laboratory, and home use; Medical diagnostic testing apparatus to test for cardiac markers; Medical diagnostic testing apparatus for conducting antibody tests; Rapid medical diagnostic testing apparatus for conducting antibody tests; Medical diagnostic antibody diagnostic testing apparatus for conducting antibody tests for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and amount of vitamin D; Rapid medical diagnostic testing apparatus to check for the presence and amount of Vitamin D; Medical diagnostic testing apparatus to check for the presence and amount of Vitamin D for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and amount of opioids; Rapid medical diagnostic testing apparatus to check for the presence and amount of opioids; Medical diagnostic testing apparatus to check for the presence and amount of opioids for point of care, laboratory, and home use; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for rapid testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and size of tumors; Rapid medical diagnostic testing apparatus to check for the presence and size of tumors; Medical diagnostic testing apparatus to check for the presence and size of tumors for point of care, laboratory, and home use; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA from self-collected nasal swab specimens; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA with isothermal amplification (LAMP) and test results displayed via LED indicators; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA with Positive Internal Control (PIC) and Lysis Internal Control (LIC) contained within the test unit; Syndromic infectious disease testing devices for medical use; Syndromic Infectious disease testing devices for medical use for testing for severe acute respiratory syndrome; Nucleic acid testing devices for medical use for testing for qualitative detection of respiratory viral and bacterial nucleic acids

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 20, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 20, 2025 AITU
SOU TEAS EXTENSION RECEIVED
May 28, 2025 EEXT
SOU EXTENSION 5 FILED
May 27, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 27, 2024 EX4G
SOU EXTENSION 4 FILED
Nov 26, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EEXT
SOU EXTENSION 3 GRANTED
May 24, 2024 EX3G
SOU EXTENSION 3 FILED
May 24, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 22, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 18, 2023 EX1G
SOU EXTENSION 1 FILED
May 18, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 18, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2021 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 28, 2021 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 28, 2021 PARI
NEW APPLICATION ENTERED
Jul 22, 2021 NWAP